UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$412M |
| 3 |
TAL Education Group
TAL
|
+$200M |
| 4 |
PPD
PPD, Inc. Common Stock
PPD
|
+$184M |
| 5 |
Intuit
INTU
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.43B |
| 2 |
NetEase
NTES
|
+$245M |
| 3 |
Goldman Sachs
GS
|
+$161M |
| 4 |
PPLI
People Inc
PPLI
|
+$114M |
| 5 |
Baidu
BIDU
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Ennis
EBF
$564M
| $501K | ﹤0.01% |
28,737
+4,946
| +21% | +$86.7K |
|
2102
Ethan Allen Interiors
ETD
$603M
| $500K | ﹤0.01% |
36,920
| – | – |
|
2103
DMC Global
BOOM
$157M
| $498K | ﹤0.01% |
+15,115
| New | +$477K |
|
|
MYOV
2104
DELISTED
Myovant Sciences Ltd.
MYOV
| $497K | ﹤0.01% |
35,346
-13,603
| -28% | -$253K |
|
|
GOOD
2105
Gladstone Commercial Corp
GOOD
$627M
| $496K | ﹤0.01% |
29,438
+1,474
| +5% | +$26.9K |
|
|
SWTX
2106
DELISTED
SpringWorks Therapeutics
SWTX
| $496K | ﹤0.01% |
+10,400
| New | +$443K |
|
|
AERI
2107
DELISTED
Aerie Pharmaceuticals
AERI
| $495K | ﹤0.01% |
42,076
-1,168
| -3% | -$14.2K |
|
2108
Center Bancorp
CNOB
$1.78B
| $494K | ﹤0.01% |
35,123
+5,771
| +20% | +$84K |
|
2109
Extreme Networks
EXTR
$3.15B
| $493K | ﹤0.01% |
122,711
+5,760
| +5% | +$25K |
|
2110
The Bancorp
TBBK
$2.84B
| $493K | ﹤0.01% |
57,089
+1,209
| +2% | +$11.1K |
|
|
HSKA
2111
DELISTED
Heska Corp
HSKA
| $491K | ﹤0.01% |
4,968
+2,192
| +79% | +$217K |
|
2112
Alaunos Therapeutics
TCRT
$4.86M
| $487K | ﹤0.01% |
1,288
-28
| -2% | -$12.4K |
|
2113
BrightView Holdings
BV
$1.07B
| $487K | ﹤0.01% |
42,721
+800
| +2% | +$9.6K |
|
|
TRUE
2114
DELISTED
TrueCar
TRUE
| $487K | ﹤0.01% |
97,395
-20,372
| -17% | -$85.9K |
|
2115
BGC Group
BGC
$4.89B
| $486K | ﹤0.01% |
202,701
+10,607
| +6% | +$27.7K |
|
|
FLXN
2116
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $484K | ﹤0.01% |
46,524
+5,092
| +12% | +$62.4K |
|
2117
Marcus & Millichap
MMI
$1.19B
| $484K | ﹤0.01% |
17,596
| – | – |
|
|
AZRE
2118
DELISTED
Azure Power Global Limited
AZRE
| $483K | ﹤0.01% |
16,208
| – | – |
|
|
DBD
2119
DELISTED
Diebold Nixdorf Incorporated
DBD
| $482K | ﹤0.01% |
63,085
-1,374
| -2% | -$10.1K |
|
2120
Liberty Energy
LBRT
$3.25B
| $482K | ﹤0.01% |
60,273
-2,000
| -3% | -$13.9K |
|
|
KDMN
2121
DELISTED
Kadmon Holdings, Inc.
KDMN
| $479K | ﹤0.01% |
122,273
+11,383
| +10% | +$47.8K |
|
2122
Option Care Health
OPCH
$3.56B
| $479K | ﹤0.01% |
35,825
+4,100
| +13% | +$49.8K |
|
|
PDLI
2123
DELISTED
PDL BioPharma, Inc.
PDLI
| $478K | ﹤0.01% |
151,896
| – | – |
|
|
SPPI
2124
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $476K | ﹤0.01% |
116,768
+25,276
| +28% | +$96.1K |
|
2125
Diageo
DEO
$53.6B
| $476K | ﹤0.01% |
+3,456
| New | +$477K |
|
Similar funds
UBS AM's Q3 2020 Portfolio in Review
As of Q3 2020, UBS AM held 2,541 positions worth $186B, up 14% from $164B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q3 2020 filing shows 79 new, 1,449 increased, 718 reduced and 56 closed positions. Its largest new stake was State Street Technology Select Sector SPDR ETF: 1,973,762 shares worth $115M. The largest sale was Alibaba, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q3 2020 buy was State Street Technology Select Sector SPDR ETF: 1,973,762 shares worth $115M.
- UBS AM added most to Microsoft in Q3 2020, an estimated $2.79B increase.
- UBS AM's biggest Q3 2020 reduction was Alibaba, cutting an estimated $1.43B.
- UBS AM fully exited LogMein, Inc. in Q3 2020, selling an estimated $27.8M.
- UBS AM's ten largest holdings make up 26% of its $186B portfolio in Q3 2020.
- UBS AM opened 79 new positions and closed 56 in Q3 2020.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $186B.
Based on UBS AM's 13F filing for Q3 2020, filed 13 Nov 2020.